MMDWF (Mind Medicine) Total Assets : $302.15 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Mind Medicine Total Assets?

Mind Medicine's Total Assets for the quarter that ended in Dec. 2024 was $302.15 Mil.

During the past 12 months, Mind Medicine's average Total Assets Growth Rate was 14.40% per year. During the past 3 years, the average Total Assets Growth Rate was -2.30% per year.

During the past 5 years, Mind Medicine's highest 3-Year average Total Assets Growth Rate was 159.30%. The lowest was -2.30%. And the median was 78.50%.

Total Assets is connected with ROA %. Mind Medicine's annualized ROA % for the quarter that ended in Dec. 2024 was -44.69%. Total Assets is also linked to Revenue through Asset Turnover. Mind Medicine's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

Mind Medicine Total Assets Historical Data

The historical data trend for Mind Medicine's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Total Assets Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

81.52

164.00

169.99

124.54

302.15

Mind Medicine Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															124.54	275.53	268.15	319.77	302.15

Mind Medicine Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Mind Medicine's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	241.448	+	60.703
	=	302.15

Mind Medicine's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	241.448	+	60.703
	=	302.15

Mind Medicine (OTCPK:MMDWF) Total Assets Explanation

Total Assets is connected with ROA %.

Mind Medicine's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-138.964	/	( (319.769	+	302.151)	/ 2 )
	=	-138.964	/	310.96
	=	-44.69 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Mind Medicine's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	0	/	( (319.769	+	302.151)	/ 2 )
=	0	/	310.96
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Mind Medicine Total Assets Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (OTCPK:MMDWF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).